cleerlyhealth.comHealthcare / Digital HealthFounded: 2016Funding to Date: $286.4MM
Cleerly, founded in 2016, is a digital healthcare company using AI to create a new standard of care for heart disease. The Cleerly platform is aiming to differentiate itself by using AI to measure plaque build-up in the heart’s arteries versus using indirect markers, like risk factors and symptoms of disease to help clinicians identify and define heart disease earlier and provide personalized treatment plans to patients.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
07/25/2022 | Series C | $230MM | $xx.xx | $624.64MM | Breyer Capital, Cigna Ventures, Digitx Partners, Fidelity Management, Heartland Healthcare Capital Funds, Lrvhealth, Mirae Asset Capital, New Leaf Ventures, Novartis, Peter Thiel, Piper Sandler, Pura Vida Investments, Sands Capital, T. Rowe Price Associates, Vensana Capital | |
Price per Share
$xx.xx
Shares Outstanding
19,523,604
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Breyer Capital, Cigna Ventures, Digitx Partners, Fidelity Management, Heartland Healthcare Capital Funds, Lrvhealth, Mirae Asset Capital, New Leaf Ventures, Novartis, Peter Thiel, Piper Sandler, Pura Vida Investments, Sands Capital, T. Rowe Price Associates, Vensana Capital
|
||||||
06/21/2021 | Series B-1 | $16.8MM | $xx.xx | $114.1MM | Cigna Ventures, Digitx Partners, Lrvhealth, New Leaf Venture Partners, The American College Of Cardiology, Vensana Capital | |
Price per Share
$xx.xx
Shares Outstanding
3,853,457
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Cigna Ventures, Digitx Partners, Lrvhealth, New Leaf Venture Partners, The American College Of Cardiology, Vensana Capital
|
||||||
06/21/2021 | Series B | $28.1MM | $xx.xx | $114.1MM | Cigna Ventures, Digitx Partners, Lrvhealth, New Leaf Venture Partners, The American College Of Cardiology, Vensana Capital | |
Price per Share
$xx.xx
Shares Outstanding
8,408,926
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Cigna Ventures, Digitx Partners, Lrvhealth, New Leaf Venture Partners, The American College Of Cardiology, Vensana Capital
|
||||||
08/10/2017 | Series A | $11.49MM | $xx.xx | $32.84MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
3,439,646
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|